Orthofix Medical Inc. Deferred Tax Liabilities, Gross
Orthofix Medical Inc. (OFIX) had Deferred Tax Liabilities, Gross of $11.10 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-24
- 2025-12-31: Deferred Tax Liabilities, Gross $11.10M.
- 2024-12-31: Deferred Tax Liabilities, Gross $14.83M.
- 2023-12-31: Deferred Tax Liabilities, Gross $16.16M.
- 2022-12-31: Deferred Tax Liabilities, Gross $11.30M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $11.10M 10-K · filed 2026-02-24 |
| 2024-12-31 | $14.83M 10-K · filed 2026-02-24 |
| 2023-12-31 | $16.16M 10-K · filed 2025-02-25 |
| 2022-12-31 | $11.30M 10-K · filed 2024-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |